Skip to main content
Premium Trial:

Request an Annual Quote

European Union Extends Review of Agilent, Varian Deal

NEW YORK (GenomeWeb News) – European Union regulators have extended their review deadline to Jan. 20 from the previous Jan. 6 on the proposed acquisition of Varian by Agilent Technologies.

According to a Reuters report today, EU regulators extended the deadline to make a decision on the deal after Agilent agreed to remedies for competition concerns. Those remedies were not specified, and Agilent officials did not return a call seeking comment before this article was published.

Agilent had reached an agreement in July to acquire Varian for around $1.5 billion. The firms said at the time that they expected to close the deal before the end of this year.

In September, the US Federal Trade Commission asked Varian and Agilent for additional information in connection with the proposed merger.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.